DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 14.96
(-1.45%)
CNY 14.96
(-1.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.24 Billion CNY | 2.72% |
| 2022 | 8.03 Billion CNY | 25.61% |
| 2021 | 6.39 Billion CNY | 13.98% |
| 2020 | 5.6 Billion CNY | 27.53% |
| 2019 | 4.39 Billion CNY | 19.22% |
| 2018 | 3.68 Billion CNY | 23.49% |
| 2017 | 2.98 Billion CNY | 18.41% |
| 2016 | 2.52 Billion CNY | 16.79% |
| 2015 | 2.16 Billion CNY | 17.99% |
| 2014 | 1.83 Billion CNY | 26.98% |
| 2013 | 1.44 Billion CNY | 21.26% |
| 2012 | 1.18 Billion CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.11 Billion CNY | -10.89% |
| 2024 Q1 | 2.37 Billion CNY | 13.58% |
| 2024 Q3 | 2.15 Billion CNY | 2.14% |
| 2023 Q4 | 2.08 Billion CNY | 0.5% |
| 2023 Q1 | 2.26 Billion CNY | -0.79% |
| 2023 Q2 | 2.22 Billion CNY | -2.05% |
| 2023 FY | 8.24 Billion CNY | 2.72% |
| 2023 Q3 | 2.07 Billion CNY | -6.52% |
| 2022 Q2 | 1.9 Billion CNY | -2.18% |
| 2022 FY | 8.03 Billion CNY | 25.61% |
| 2022 Q4 | 2.28 Billion CNY | 20.24% |
| 2022 Q3 | 1.9 Billion CNY | 0.07% |
| 2022 Q1 | 1.94 Billion CNY | 16.45% |
| 2021 Q1 | 1.59 Billion CNY | 2.39% |
| 2021 Q3 | 1.57 Billion CNY | 1.63% |
| 2021 FY | 6.39 Billion CNY | 13.98% |
| 2021 Q2 | 1.55 Billion CNY | -2.98% |
| 2021 Q4 | 1.66 Billion CNY | 5.85% |
| 2020 Q3 | 1.4 Billion CNY | 2.69% |
| 2020 Q2 | 1.36 Billion CNY | 7.63% |
| 2020 FY | 5.6 Billion CNY | 27.53% |
| 2020 Q1 | 1.27 Billion CNY | 6.37% |
| 2020 Q4 | 1.56 Billion CNY | 11.0% |
| 2019 FY | 4.39 Billion CNY | 19.22% |
| 2019 Q3 | 1.1 Billion CNY | 2.04% |
| 2019 Q4 | 1.19 Billion CNY | 8.62% |
| 2019 Q1 | 1.02 Billion CNY | -3.86% |
| 2019 Q2 | 1.07 Billion CNY | 5.64% |
| 2018 Q1 | 823.64 Million CNY | -3.53% |
| 2018 Q4 | 1.06 Billion CNY | 14.87% |
| 2018 FY | 3.68 Billion CNY | 23.49% |
| 2018 Q2 | 877.88 Million CNY | 6.59% |
| 2018 Q3 | 925.19 Million CNY | 5.39% |
| 2017 Q3 | 741.52 Million CNY | 3.07% |
| 2017 Q1 | 672.94 Million CNY | -6.58% |
| 2017 Q2 | 719.43 Million CNY | 6.91% |
| 2017 FY | 2.98 Billion CNY | 18.41% |
| 2017 Q4 | 853.74 Million CNY | 15.13% |
| 2016 Q2 | 596.8 Million CNY | 3.8% |
| 2016 Q1 | 574.93 Million CNY | 0.0% |
| 2016 Q3 | 631.09 Million CNY | 5.74% |
| 2016 Q4 | 720.31 Million CNY | 14.14% |
| 2016 FY | 2.52 Billion CNY | 16.79% |
| 2015 Q1 | 513.79 Million CNY | 0.0% |
| 2015 Q2 | 513.79 Million CNY | 0.0% |
| 2015 FY | 2.16 Billion CNY | 17.99% |
| 2014 FY | 1.83 Billion CNY | 26.98% |
| 2013 FY | 1.44 Billion CNY | 21.26% |
| 2012 FY | 1.18 Billion CNY | 0.0% |